Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-17 Purchase |
2023-07-19 4:17 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) |
View |
| 2023-07-17 Purchase |
2023-07-19 4:15 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner |
479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) |
View |
| 2023-07-17 Purchase |
2023-07-19 2:54 pm |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
700,000 | $2.97 | $2,079,000 | 1,385,825 (Indirect) |
View |
| 2022-12-29 Purchase |
2023-01-03 4:24 pm |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
500,000 | $5 | $2,500,000 | 1,209,275 (Indirect) |
View |
| 2022-12-29 Purchase |
2023-01-03 07:05 am |
Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director |
10,000 | $4.9989 | $49,989 | 10,000 (Direct) |
View |
| 2022-11-30 Purchase |
2022-12-01 4:35 pm |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
1,502 | $6.657 | $10,000 | 6,142 (Direct) |
View |
| 2022-11-11 Purchase |
2022-11-14 4:12 pm |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
2,500 | $6.798 | $16,995 | 351,030 (Direct) |
View |
| 2022-11-07 Purchase |
2022-11-09 4:29 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) |
View |
| 2022-11-07 Purchase |
2022-11-09 4:25 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Equity Swap |
2024-02-14 4:02 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
17,713,600 | $0 | 0 (Indirect) |
View |
| 2024-02-14 Equity Swap |
2024-02-14 4:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director |
10,000 | $0 | 0 (Direct) |
View |
| 2024-02-14 Equity Swap |
2024-02-14 4:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
17,713,600 | $0 | 0 (Indirect) |
View |
| 2024-02-14 Equity Swap |
2024-02-14 4:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Director |
388,324 | $0 | 0 (Direct) |
View |
| 2024-02-14 Equity Swap |
2024-02-14 4:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. President and CFO |
8,150 | $0 | 0 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-07 4:03 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
251,084 | $0.32 | 732,668 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-07 4:03 pm |
N/A 2030-12-23 |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
251,084 | $0 | 732,668 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 5:30 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | Stein Steven H Director |
22,750 | $0 | 22,750 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 5:30 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director |
22,750 | $0 | 22,750 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 5:29 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director |
22,750 | $0 | 22,750 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 5:29 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
22,750 | $0 | 22,750 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 5:28 pm |
N/A 2033-06-12 |
Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Director |
22,750 | $0 | 22,750 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:02 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer |
16,250 | $0 | 16,250 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:01 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
21,250 | $0 | 21,250 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:01 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:00 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 07:00 am |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
45,625 | $0 | 45,625 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:03 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
127,500 | $0 | 127,500 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:03 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer |
97,500 | $0 | 97,500 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:03 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:01 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 07:00 am |
N/A 2033-02-17 |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
273,750 | $0 | 273,750 (Direct) |
View |
| 2022-10-17 Option Award |
2022-10-19 07:18 am |
N/A 2032-10-17 |
Theseus Pharmaceuticals Inc. | THRX | Stein Steven H Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:13 pm |
N/A 2032-06-09 |
Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:12 pm |
N/A 2032-06-09 |
Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Chairman |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:10 pm |
N/A 2032-06-09 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2022-06-13 5:15 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner |
0 | $0 | 4,294,621 (Indirect) |
View |
| 2022-05-17 Option Award |
2022-05-18 4:27 pm |
N/A 2032-05-17 |
Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director |
60,000 | $0 | 60,000 (Direct) |
View |